GO:0010743 regulation of macrophage derived foam cell differentiation: Atherosclerosis Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010743 describes any process that modulates the rate, frequency, or extent of macrophage derived foam cell differentiation, the transformation of macrophages into lipid-laden foam cells.
• Foam cell formation is a hallmark of early atherosclerotic lesions and is driven by scavenger receptor-mediated uptake of modified lipoproteins, especially CD36 and SR-A.
• Key regulatory nodes include CD36, SR-BI, Kir2.1, ER stress pathways, and immune cells such as CD4+CD25+ regulatory T cells.
• Dysregulated foam cell differentiation contributes to atherosclerosis, diabetic kidney disease, and prostate pathology, making it a therapeutic target.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate regulators in macrophage foam cell biology.
• Understanding this GO term supports drug discovery, biomarker identification, and mechanistic studies in cardiometabolic disease.
Description
Macrophage derived foam cells are lipid-laden macrophages that accumulate in the arterial intima and are a defining feature of early atherosclerotic plaques. The Gene Ontology term GO:0010743, regulation of macrophage derived foam cell differentiation, encompasses any process that modulates the rate, frequency, or extent of the transition from a macrophage to a foam cell. This transition involves increased uptake of modified low-density lipoprotein (LDL) via scavenger receptors, impaired cholesterol efflux, and altered intracellular lipid handling. Because foam cell formation is causally linked to atherosclerosis and other inflammatory conditions, understanding its regulation is of major interest to cardiovascular researchers, immunologists, and drug developers. Experimental evidence has identified multiple regulatory layers, including scavenger receptor expression, endoplasmic reticulum (ER) stress, ion channel activity, and immune cell crosstalk. For example, CD36 upregulation under ER stress promotes foam cell formation, while SR-BI downregulation by lysophosphatidic acid blocks cholesterol efflux and accelerates lipid accumulation. Regulatory T cells can suppress foam cell formation, highlighting the immune modulation of this process. These findings underscore the complexity of GO:0010743 and the need for robust experimental models to dissect causal mechanisms. This article provides a research-grade overview of GO:0010743, integrating the QuickGO definition with verified PubMed literature. It covers the biological process, key genes, disease relevance, and state-of-the-art methods including CRISPR genome editing, transcriptomics, and imaging. The goal is to equip researchers with a concise, citable resource for studying macrophage foam cell differentiation and its regulation.
regulation of macrophage derived foam cell differentiation At A Glance
| GO ID | GO:0010743 |
|---|---|
| GO term | regulation of macrophage derived foam cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the rate, frequency, or extent of macrophage-to-foam-cell transition, a key step in atherosclerosis and lipid storage pathology. |
| Definition source | QuickGO definition based on published literature. |
| Related processes | Cholesterol efflux, scavenger receptor signaling, ER stress response, immune regulation. |
| Disease relevance | Atherosclerosis, diabetic kidney disease, prostate pathology. |
| Key regulators | CD36, SR-BI, Kir2.1, ER stress-CHOP, regulatory T cells. |
What Is GO:0010743?
GO:0010743, regulation of macrophage derived foam cell differentiation, is a biological process that modulates the rate, frequency, or extent of macrophage derived foam cell differentiation. In this process, a macrophage acquires the specialized features of a foam cell, a cell type containing lipids in small vacuoles, typically seen in atherosclerotic lesions and other conditions. The term covers any regulatory input, including positive or negative regulation, that influences the conversion of macrophages into foam cells.
Why Is regulation of macrophage derived foam cell differentiation Important in Cell Biology?
Regulation of macrophage derived foam cell differentiation is central to cardiovascular pathology because foam cells are the earliest cellular hallmark of atherosclerotic plaques and drive lesion progression. Beyond atherosclerosis, foam cell formation contributes to diabetic kidney disease and prostate pathology, linking this GO term to multiple metabolic and inflammatory disorders. Understanding its regulatory mechanisms can reveal therapeutic targets for reducing lipid accumulation and inflammation, and can inform biomarker discovery for disease stratification.
• Foam cells are a defining feature of early atherosclerotic lesions and contribute to plaque instability.
• CD36-mediated lipid uptake and ER stress are key drivers of foam cell formation, offering druggable nodes.
• SR-BI downregulation impairs cholesterol efflux and promotes foam cell differentiation.
• Kir2.1 channel activity influences human monocyte-derived foam cell maturation.
• Regulatory T cells can suppress foam cell formation, linking adaptive immunity to this process.
• Dysregulated foam cell differentiation is implicated in diabetic kidney disease and prostate pathology.
• The process is relevant to drug discovery for atherosclerosis and metabolic syndrome.
• CRISPR models enable causal validation of candidate regulators in macrophage foam cell biology.
• Bioinformatics and transcriptomics can identify novel biomarkers and pathways linked to this GO term.
• Understanding this term supports precision medicine approaches targeting lipid-laden macrophages.
What Happens During regulation of macrophage derived foam cell differentiation?
Scavenger receptor-mediated lipid uptake
In simple terms: Macrophages take in modified fats through special receptor proteins, becoming foam cells.
The initial step in macrophage derived foam cell differentiation involves the uptake of modified low-density lipoprotein (LDL) via scavenger receptors such as CD36 and SR-A. CD36 expression is upregulated under endoplasmic reticulum (ER) stress, leading to increased lipid accumulation and foam cell formation. This process is a key regulatory node for GO:0010743, as modulating CD36 levels directly affects the rate of foam cell differentiation.
Cholesterol efflux and SR-BI regulation
In simple terms: Cells try to pump out excess cholesterol, but when this fails, they turn into foam cells.
Cholesterol efflux is mediated by transporters such as SR-BI, which facilitates the removal of cholesterol from macrophages. Lysophosphatidic acid (LPA) directly induces macrophage-derived foam cell formation by blocking the expression of SR-BI, thereby impairing cholesterol efflux and promoting lipid accumulation. Thus, regulation of SR-BI is a critical determinant of foam cell differentiation and is a target for modulating GO:0010743.
ER stress and CD36 upregulation
In simple terms: Stress inside the cell's protein factory increases fat receptors, pushing macrophages to become foam cells.
Endoplasmic reticulum (ER) stress promotes macrophage-derived foam cell formation by up-regulating CD36 expression. The ER stress-CHOP pathway is involved, and inhibition of this pathway by D4F alleviates foam cell apoptosis by reducing CD36 expression. These findings establish ER stress as a positive regulator of foam cell differentiation and a potential therapeutic target.
Ion channel modulation by Kir2.1
In simple terms: Ion channels on the cell surface help control how macrophages mature into foam cells.
The inward rectifier potassium channel Kir2.1 plays a role in human monocyte-derived foam cell maturation. Modulation of Kir2.1 activity affects the differentiation process, suggesting that ion channel function is part of the regulatory network of GO:0010743. This highlights the diversity of regulatory inputs beyond lipid metabolism.
Immune regulation by regulatory T cells
In simple terms: Certain immune cells can put the brakes on foam cell formation.
CD4+CD25+ regulatory T cells (Tregs) play a role in macrophage-derived foam cell formation. Tregs can suppress foam cell differentiation, indicating that adaptive immune mechanisms regulate this process. This immune crosstalk adds another layer of regulation to GO:0010743 and suggests that immunomodulation could influence foam cell accumulation.
Key Genes Involved in GO:0010743 regulation of macrophage derived foam cell differentiation
The following genes and proteins have been experimentally linked to the regulation of macrophage derived foam cell differentiation (GO:0010743) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD36 | Scavenger receptor mediating uptake of modified LDL; upregulated by ER stress | Knockout reduces foam cell formation; target for anti-atherosclerotic therapy |
| SR-BI | Cholesterol efflux transporter; downregulated by LPA | Overexpression enhances efflux; knockout promotes foam cell formation |
| Kir2.1 | Inward rectifier potassium channel involved in monocyte-derived foam cell maturation | Modulation affects differentiation; potential target in atherosclerosis |
| CHOP | ER stress-induced transcription factor; regulates CD36 expression | Inhibition reduces foam cell apoptosis and lipid accumulation |
| CNP | C-type natriuretic peptide; ameliorates macrophage inflammatory response | Therapeutic potential in atherosclerosis by reducing inflammation |
| CXCL17 | Chemokine upregulated in prostate foam cells | Biomarker for prostate foam cell heterogeneity |
| LPA | Lysophosphatidic acid; blocks SR-BI expression | Induces foam cell formation; target for intervention |
| Treg markers (CD4, CD25) | Regulatory T cells suppress foam cell formation | Immunomodulatory strategies for atherosclerosis |
| D4F | Apolipoprotein A-I mimetic peptide; inhibits CD36 and ER stress | Reduces foam cell apoptosis; therapeutic candidate |
| SR-A | Scavenger receptor for modified LDL (implied in foam cell formation) | Classic marker of foam cells; target for KO studies |
| ABCA1 | Cholesterol efflux transporter (related to SR-BI pathway) | Potential target to enhance efflux |
| ABCG1 | Cholesterol efflux transporter (related to SR-BI pathway) | Potential target to enhance efflux |
| IL-10 | Anti-inflammatory cytokine (implied in Treg suppression) | Modulates foam cell formation via immune regulation |
| TGF-beta | Anti-inflammatory cytokine (implied in Treg suppression) | May suppress foam cell differentiation |
| NF-kB | Inflammatory transcription factor (implied in CNP pathway) | Inhibition reduces foam cell formation |
| PPAR-gamma | Nuclear receptor regulating lipid metabolism (implied) | Modulates CD36 expression |
| LXR | Liver X receptor regulating cholesterol efflux (implied) | Target for enhancing efflux |
| SREBP | Sterol regulatory element-binding protein (implied) | Regulates lipid uptake and storage |
How Is regulation of macrophage derived foam cell differentiation Regulated?
Regulation of macrophage derived foam cell differentiation (GO:0010743) is controlled by multiple signaling pathways. ER stress activates the CHOP pathway, which upregulates CD36 and promotes foam cell formation. Lysophosphatidic acid (LPA) signaling blocks SR-BI expression, impairing cholesterol efflux and accelerating foam cell differentiation. Ion channel activity, particularly Kir2.1, modulates monocyte-derived foam cell maturation. Immune regulation by CD4+CD25+ regulatory T cells can suppress foam cell formation, indicating that adaptive immunity provides negative regulatory input. Additionally, CNP ameliorates macrophage inflammatory responses, suggesting that natriuretic peptide signaling may negatively regulate foam cell differentiation. These pathways collectively tune the rate and extent of foam cell formation in atherosclerotic lesions.
regulation of macrophage derived foam cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD36 | Atherosclerosis; foam cell formation | Knockout mouse or human macrophage KO via CRISPR |
| SR-BI | Atherosclerosis; impaired cholesterol efflux | Overexpression or knockout in macrophages |
| Kir2.1 | Atherosclerosis; monocyte-derived foam cell maturation | Point mutation or knockout in human monocytes |
| CNP | Atherosclerosis; macrophage inflammation | Overexpression in mouse models |
| CXCL17 | Prostate foam cell pathology | Knockout or overexpression in prostate macrophages |
Atherosclerosis
Atherosclerosis is the primary disease linked to GO:0010743. Macrophage-derived foam cells accumulate in the arterial intima and form the fatty streak, the earliest visible lesion of atherosclerosis. CD36-mediated lipid uptake and ER stress promote foam cell formation, while SR-BI downregulation impairs cholesterol efflux, exacerbating lipid accumulation. CNP ameliorates macrophage inflammatory response and atherosclerosis, highlighting therapeutic potential. D4F alleviates foam cell apoptosis by inhibiting CD36 and ER stress, further supporting the link between this GO term and atherosclerotic plaque development.
Diabetic kidney disease
Bioinformatics prediction and experimental verification have identified key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice. Although the exact role of foam cells in diabetic kidney disease is not fully defined in the verified literature, the overlap of lipid metabolism and inflammation suggests that GO:0010743 may contribute to renal pathology. Further studies are needed to establish causality.
Prostate pathology
Characterization of prostate macrophage heterogeneity in a mouse model of steroid hormone imbalance revealed foam cell markers and CXCL17 upregulation. This suggests that macrophage-derived foam cells can form in the prostate under hormonal imbalance, extending the relevance of GO:0010743 beyond cardiovascular disease. The study highlights the need to understand tissue-specific regulation of foam cell differentiation.
From regulation of macrophage derived foam cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD36 loss reduce foam cell formation? | CRISPR knockout of CD36 in human macrophages or mouse models |
| Does SR-BI overexpression enhance cholesterol efflux? | CRISPR knock-in or overexpression of SR-BI in macrophages |
| Does Kir2.1 point mutation affect foam cell maturation? | CRISPR point mutation in human monocytes |
| Does CNP overexpression ameliorate atherosclerosis? | CRISPR knock-in or transgenic overexpression in mice |
| Does CXCL17 upregulation correlate with prostate foam cells? | Knockout or tagged knock-in in mouse prostate macrophages |
| Does Treg depletion increase foam cell formation? | CRISPR knockout of Treg markers or adoptive transfer |
How to Study the regulation of macrophage derived foam cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify biomarkers and pathways in foam cell models |
| Oil Red O staining | Lipid droplet accumulation | Confirm foam cell phenotype |
| Western blot | Protein expression levels | Measure CD36, SR-BI, CHOP |
| Flow cytometry | Scavenger receptor surface expression | Quantify CD36 on macrophages |
| CRISPR knockout | Gene function loss | Test causal role of candidate genes |
| CRISPR knock-in | Precise mutation or tag insertion | Study point mutations or tagged proteins |
| Immunofluorescence | Protein localization and lipid co-staining | Visualize foam cells in tissue |
| Bioinformatics | Pathway enrichment and network analysis | Predict key regulators from omics data |
Transcriptomics and bioinformatics
RNA sequencing and bioinformatics prediction can identify key biomarkers and pathways associated with macrophage derived foam cell differentiation. Transcriptome sequencing in mouse models of diabetic kidney disease has revealed candidate genes linked to lipid metabolism and inflammation. These approaches help prioritize targets for functional validation in GO:0010743 research.
Lipid staining and imaging
Oil Red O and Filipin staining are commonly used to visualize lipid droplets in foam cells. Imaging flow cytometry and confocal microscopy can quantify lipid accumulation and foam cell morphology. These methods are essential for confirming the foam cell phenotype in vitro and in situ.
Protein and pathway analysis
Western blotting and immunostaining can measure CD36, SR-BI, and CHOP protein levels to assess regulatory changes. Flow cytometry can quantify scavenger receptor expression on macrophages. These techniques link molecular changes to foam cell differentiation.
CRISPR screening and functional genomics
CRISPR library screening enables unbiased discovery of genes that regulate foam cell differentiation. Pooled knockout screens in macrophage cell lines can identify positive and negative regulators of GO:0010743. Follow-up validation using individual knockouts or knock-ins confirms causality.
How CRISPR Can Be Used to Study GO:0010743 regulation of macrophage derived foam cell differentiation
Knockout
CRISPR knockout of candidate genes such as CD36, SR-BI, or Kir2.1 in macrophages can determine whether they are required for foam cell differentiation. For example, CD36 knockout reduces lipid uptake and foam cell formation, validating its role in GO:0010743. Knockout models are essential for causal inference in atherosclerosis research.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to study structure-function relationships, such as in Kir2.1 channel activity during foam cell maturation. This approach allows precise interrogation of regulatory domains without complete gene loss. Point mutations can also model human genetic variants associated with cardiovascular risk.
Knock-in
CRISPR knock-in can insert tags, reporters, or human disease variants into the genome to track protein expression or model disease-associated mutations. For example, knocking in a fluorescent tag on CD36 enables live-cell imaging of scavenger receptor dynamics during foam cell formation. Knock-in models are valuable for studying regulatory elements and isoform-specific functions.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can increase the levels of protective genes such as SR-BI or CNP to test whether they suppress foam cell differentiation. Overexpression of SR-BI enhances cholesterol efflux and reduces foam cell formation, supporting its therapeutic potential. CNP overexpression ameliorates macrophage inflammation and atherosclerosis in mouse models.
How EDITGENE Supports regulation of macrophage derived foam cell differentiation Research
Researchers studying regulation of macrophage derived foam cell differentiation-related genes often need to determine whether a candidate gene is causally involved in lipid accumulation, cholesterol efflux, or inflammatory signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery, from knockout and point mutation to knock-in and overexpression, complemented by library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for regulation of macrophage derived foam cell differentiation research.
Frequently Asked Questions About regulation of macrophage derived foam cell differentiation
What is GO:0010743?
GO:0010743 is the Gene Ontology term for regulation of macrophage derived foam cell differentiation, a biological process that modulates the rate, frequency, or extent of macrophage-to-foam-cell transition.
What genes are involved in regulation of macrophage derived foam cell differentiation?
Key genes include CD36, SR-BI, Kir2.1, CHOP, CNP, and CXCL17, as well as immune regulators like CD4+CD25+ regulatory T cells.
How does CD36 regulate foam cell formation?
CD36 is a scavenger receptor that mediates uptake of modified LDL; its upregulation by ER stress promotes foam cell formation.
What is the role of SR-BI in foam cell differentiation?
SR-BI mediates cholesterol efflux; its downregulation by lysophosphatidic acid impairs efflux and promotes foam cell formation.
How is ER stress linked to foam cell formation?
ER stress upregulates CD36 via the CHOP pathway, increasing lipid uptake and promoting foam cell differentiation.
Can regulatory T cells suppress foam cell formation?
Yes, CD4+CD25+ regulatory T cells can suppress macrophage-derived foam cell formation, indicating immune regulation of this process.
What diseases are associated with macrophage derived foam cells?
Atherosclerosis is the primary disease, but foam cells are also implicated in diabetic kidney disease and prostate pathology.
What experimental models are used to study GO:0010743?
Common models include CRISPR knockout/knock-in macrophages, mouse atherosclerosis models, and transcriptomic profiling.
How can CRISPR screening help identify regulators of foam cell differentiation?
CRISPR library screening enables unbiased discovery of genes that positively or negatively regulate foam cell formation, followed by validation.
What services does EDITGENE offer for foam cell research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to macrophage foam cell biology.
Conclusion
GO:0010743, regulation of macrophage derived foam cell differentiation, is a critical biological process at the intersection of lipid metabolism, inflammation, and cardiovascular disease. The verified literature highlights key regulators such as CD36, SR-BI, Kir2.1, ER stress pathways, and regulatory T cells, all of which modulate foam cell formation. Understanding these mechanisms offers opportunities for therapeutic intervention in atherosclerosis and related disorders. CRISPR-based models and bioinformatics approaches are indispensable for dissecting the causal roles of candidate genes in this process. EDITGENE's comprehensive services empower researchers to accelerate discovery and translate findings into clinical applications.
References
- 1. Bao Q et al.. 2024. CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis.. Circ Res 134(8):e72-e91 PMID: 38456298
- 2. Silver SV et al.. 2024. Characterization of prostate macrophage heterogeneity, foam cell markers, and CXCL17 upregulation in a mouse model of steroid hormone imbalance.. Sci Rep 14(1):21029 PMID: 39251671
- 3. Zhao J et al.. 2022. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.. PeerJ 10:e13932 PMID: 36157062
- 4. Zhang W et al.. 2016. Role of Kir2.1 in human monocyte-derived foam cell maturation.. J Cell Mol Med 20(3):403-12 PMID: 26689595
- 5. Chen L et al.. 2017. Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI.. Biochem Biophys Res Commun 491(3):587-594 PMID: 28765047
- 6. Yao S et al.. 2014. Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression.. J Biol Chem 289(7):4032-42 PMID: 24366867
- 7. Yao S et al.. 2015. D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathway.. J Lipid Res 56(4):836-47 PMID: 25635126
- 8. Lin J et al.. 2010. The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.. J Lipid Res 51(5):1208-17 PMID: 20007839
